Bastiano Sanna Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Bastiano Sanna is EVP, Cell & Genetic Therapies of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 32,038 shares of VRTX, which is worth approximately $15 Million. The most recent transaction as insider was on Apr 05, 2022, when has been sold 3,163 shares (Common Stock) at a price of $275.23 per share, resulting in proceeds of $870,553. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32K

0% 3M change

0% 12M change

Total Value Held $15 Million

Bastiano Sanna Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 05 2022	SELL Open market or private sale	$870,553 $275.23 p/Share	3,163 Reduced 6.8%	43,343 Common Stock
Apr 04 2022	SELL Open market or private sale	$150,481 $267.76 p/Share	562 Reduced 1.19%	46,506 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$353,593 $263.09 p/Share	1,344 Reduced 2.78%	47,068 Common Stock
Mar 17 2022	SELL Open market or private sale	$530,627 $250.06 p/Share	2,122 Reduced 4.2%	48,412 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$799,602 $232.51 p/Share	3,439 Reduced 6.37%	50,534 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$232,747 $237.74 p/Share	979 Reduced 1.78%	53,973 Common Stock
Feb 02 2022	SELL Open market or private sale	$262,714 $252.61 p/Share	1,040 Reduced 1.86%	54,952 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$128,155 $243.64 p/Share	526 Reduced 0.93%	55,992 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	23,942 Added 29.76%	56,518 Common Stock
Nov 01 2021	SELL Payment of exercise price or tax liability	$141,764 $185.07 p/Share	766 Reduced 2.3%	32,576 Common Stock
Jul 30 2021	SELL Payment of exercise price or tax liability	$153,499 $200.39 p/Share	766 Reduced 2.25%	33,342 Common Stock
May 17 2021	SELL Open market or private sale	$24,239 $216.42 p/Share	112 Reduced 0.33%	34,108 Common Stock
May 03 2021	SELL Open market or private sale	$209,712 $218.45 p/Share	960 Reduced 2.74%	34,108 Common Stock
Apr 30 2021	SELL Payment of exercise price or tax liability	$166,383 $217.21 p/Share	766 Reduced 2.14%	35,068 Common Stock
Apr 05 2021	SELL Open market or private sale	$361,546 $214.44 p/Share	1,686 Reduced 4.49%	35,834 Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$287,831 $214.16 p/Share	1,344 Reduced 3.46%	37,520 Common Stock
Feb 11 2021	SELL Open market or private sale	$355,628 $210.93 p/Share	1,686 Reduced 4.16%	38,864 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$287,831 $214.16 p/Share	1,344 Reduced 3.21%	40,550 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	20,719 Added 33.09%	41,894 Common Stock

Also insider at

ACET

Adicet Bio, Inc. Healthcare

Director

Bastiano Sanna

EVP, Cell & Genetic Therapies

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account